Ozempic is a once-weekly semaglutide injection offered at Oshun in Kingston, Jamaica within Dr. Charles Rockhead's medical weight loss programme. Whether it is right for you is decided at an in-person consultation, never before it.
No obligation · Every consultation is in-person with Dr. Rockhead. Common questions · Call +1 (876) 676-6297
Every procedure at Oshun is reviewed and led by a board-certified Obstetrician and Gynaecologist. Dr. Rockhead is a physician first — the same one who treats women's health on the other side of his practice.
Three decades as a practicing OB/GYN at Amadeo Medical Group, the parent clinical practice. Every Medical Weight Loss plan is reviewed by a physician who has cared for women through pregnancy, surgery, perimenopause, and post-natal recovery.
Every Medical Weight Loss patient leaves consultation with a written plan: areas, technique, timing, recovery, cost. Returning patients refine the same plan rather than starting from scratch every visit.
Oshun's approach favours conservative, considered care over aggressive intervention. Decisions are made in conversation with you, options are presented in plain language, and consent is informed at every step.
What Ozempic is, how it is prescribed at Oshun, how it differs from Mounjaro, what the side effects are, and what a consultation costs.
Ozempic is a prescription medicine whose active substance is semaglutide. It comes in a prefilled pen and is injected under the skin once a week, according to the European Medicines Agency. Semaglutide is a GLP-1 receptor agonist, the agency says: it acts in the same way as GLP-1, a hormone made in the gut.
The honest version
Ozempic is authorised as a diabetes medicine.
In the European Union, Ozempic is authorised for type 2 diabetes, not for weight loss, according to the European Medicines Agency. In its studies of people with type 2 diabetes, the agency notes, treatment with Ozempic was also associated with a fall in body weight.
In the European Union, the semaglutide brand authorised for weight management is Wegovy, according to the European Medicines Agency. Prescribing Ozempic for weight is outside that authorised use. It is a medical decision made for one patient at a time, and at Oshun it is made only at a consultation.
The medicine is one part of the plan. Our medical weight loss page explains the whole programme: nutrition, activity, monthly follow-up, and what to expect when the medicine stops.
At Oshun, GLP-1 medicines such as Ozempic are prescribed and given by Dr. Charles Rockhead, a board-certified obstetrician and gynaecologist and the clinic's Medical Director. He reviews your medical history, your weight history and your laboratory results before any prescription is written.
Dr. Charles Rockhead, Medical Director — Oshun Cosmetic Services, Kingston.
Medical Director · Board-Certified OB/GYN · 30+ years of practice
Dr. Charles Rockhead is a board-certified Obstetrician and Gynaecologist with more than thirty years of practice in Kingston. He is the Medical Director of Oshun Cosmetic Services and the founding physician of Amadeo Medical Group, the parent clinical practice.
At Oshun, Ozempic is available only through the medical weight loss programme, and the programme begins with an in-person consultation at 9 Devon Road, Kingston. These are the steps.
Book online or message the care team on WhatsApp. Every consultation is in person at 9 Devon Road, Kingston. Virtual consultations are not currently offered.
Baseline laboratory tests are arranged before treatment: a full blood count, a comprehensive metabolic panel, a lipid panel, HbA1c, TSH and vitamin D. Bring any records of your weight history and a list of your current medications.
Dr. Rockhead reviews your medical history, your weight history and your results. He then writes an individualised plan covering medication where appropriate, nutrition, activity and monitoring. If Ozempic is part of that plan, it is prescribed then.
Once you are on the injections you are seen once a month at no additional charge. Each visit lasts 15 to 30 minutes.
Ozempic and Mounjaro are both once-weekly injections, but they contain different active substances. Ozempic contains semaglutide. Mounjaro contains tirzepatide, which acts in the same way as two gut hormones, GLP-1 and GIP, according to the European Medicines Agency.
The most common side effects of Ozempic are problems with the digestive system, such as nausea, vomiting and diarrhoea. They may affect more than 1 in 10 people and are usually mild or moderate and short-lived, according to the European Medicines Agency.
These are common patient profiles in the weight loss programme. They describe the programme, not who this medicine is authorised for. If one sounds like you, an in-person consultation at 9 Devon Road is the next step.
Patients with obesity-related conditions where weight loss directly improves the underlying condition.
Pre-diabetes managementPatients with elevated HbA1c whose primary driver is weight, and who meet the BMI criteria for treatment.
Perimenopausal weight changeWomen whose weight has increased through perimenopause or menopause and who meet the BMI criteria for treatment.
Planning surgeryTell Dr. Rockhead and your anaesthetist that you take a GLP-1 medicine. It slows stomach emptying, which matters under general anaesthetic or deep sedation.
At Oshun the first consultation starts at J$11,000, and the cost of the medicine is given to you in writing at that consultation. The monthly follow-up visit is at no additional charge while you are on the injections.
If this sounds right
Every weight loss patient at Oshun starts with a consultation, in person at 9 Devon Road, with Dr. Rockhead. Nothing is prescribed and nothing is signed until you have your plan and your quote in writing.
No obligation · Every consultation is in-person with Dr. Rockhead. Call +1 (876) 676-6297
Open any of them.
Ozempic is one part of a plan. The plan starts with a consultation.
No obligation · Every consultation is in-person with Dr. Rockhead. Call +1 (876) 676-6297